Dateline City:
KENILWORTH, N.J.
Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning Work at Merck Research Laboratories
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
proudly congratulates William C. Campbell, a retired scientist from
Merck Research Laboratories, who was jointly named the 2015 Nobel Prize
winner in Physiology or Medicine with Satoshi Omura for the discovery of
avermectin, which led to Mercks development of Mectizan (ivermectin), a
treatment for river blindness (also known as onchocerciasis) in Africa,
Latin America and Yemen.
Language:
English
Contact:
MerckMedia:Lainie Keller, 908-236-5036orClaire Gillespie, 267-305-0932orInvestors:Terri Loxam, 908-740-1986orJustin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more